SILVER SPRING, Md., June 16, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) of the Chembio Diagnostic System, Inc. (Chembio) DPP COVID-19 IgM/IgG System, a SARS-CoV-2 antibody test, due to performance concerns with the...
from PR Newswire: https://ift.tt/3dalcgr
No comments:
Post a Comment